These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17910954)

  • 1. Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.
    Miyazaki I; Asanuma M; Hozumi H; Miyoshi K; Sogawa N
    FEBS Lett; 2007 Oct; 581(25):5003-8. PubMed ID: 17910954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity.
    Miyazaki I; Asanuma M; Kikkawa Y; Takeshima M; Murakami S; Miyoshi K; Sogawa N; Kita T
    Glia; 2011 Mar; 59(3):435-51. PubMed ID: 21264950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice.
    Suemori S; Shimazawa M; Kawase K; Satoh M; Nagase H; Yamamoto T; Hara H
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3975-82. PubMed ID: 16936113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.
    Miyazaki I; Asanuma M; Diaz-Corrales FJ; Fukuda M; Kitaichi K; Miyoshi K; Ogawa N
    FASEB J; 2006 Mar; 20(3):571-3. PubMed ID: 16403784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro.
    Miyazaki I; Asanuma M; Diaz-Corrales FJ; Miyoshi K; Ogawa N
    Clin Neuropharmacol; 2005; 28(4):155-60. PubMed ID: 16062092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment.
    Shuai Y; Guo JB; Peng SQ; Zhang LS; Guo J; Han G; Dong YS
    Toxicol Lett; 2007 Apr; 170(1):66-74. PubMed ID: 17382496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity.
    Takeshima M; Murata M; Urasoe N; Murakami S; Miyazaki I; Asanuma M; Kita T
    Neurol Res; 2011 Dec; 33(10):1050-6. PubMed ID: 22196758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model.
    Mita M; Satoh M; Shimada A; Okajima M; Azuma S; Suzuki JS; Sakabe K; Hara S; Himeno S
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G877-84. PubMed ID: 18239062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation.
    Maeda T; Nagata K; Yoshida Y
    Neurosci Lett; 2008 Mar; 433(3):255-8. PubMed ID: 18255227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.
    Hozumi H; Asanuma M; Miyazaki I; Fukuoka S; Kikkawa Y; Kimoto N; Kitamura Y; Sendo T; Kita T; Gomita Y
    Toxicol Lett; 2008 Mar; 177(2):123-9. PubMed ID: 18282668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc-metallothionein: a potential mediator of antioxidant defence mechanisms in response to dopamine-induced stress.
    Eibl JK; Abdallah Z; Ross GM
    Can J Physiol Pharmacol; 2010 Mar; 88(3):305-12. PubMed ID: 20393595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of metallothionein on exposure to metals: an in vitro study on cellular models.
    Santon A; Formigari A; Irato P
    Toxicol In Vitro; 2008 Jun; 22(4):980-7. PubMed ID: 18356017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein acts as a cytoprotectant against doxorubicin toxicity.
    Kimura T; Fujita I; Itoh N; Muto N; Nakanishi T; Takahashi K; Azuma J; Tanaka K
    J Pharmacol Exp Ther; 2000 Jan; 292(1):299-302. PubMed ID: 10604962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g).
    Sogawa CA; Miyazaki I; Sogawa N; Asanuma M; Ogawa N; Furuta H
    Brain Res; 2000 Jan; 853(2):310-6. PubMed ID: 10640628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein isoforms (I+II and III) and interleukin-6 in the hippocampus of old rats: may their concomitant increments lead to neurodegeneration?
    Mocchegiani E; Giacconi R; Fattoretti P; Casoli T; Cipriano C; Muti E; Malavolta M; DiStefano G; Bertoni-Freddari C
    Brain Res Bull; 2004 Mar; 63(2):133-42. PubMed ID: 15130702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J; Mørk A; Brennum LT; Sager TN
    Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth.
    Fong L; Tan K; Tran C; Cool J; Scherer MA; Elovaris R; Coyle P; Foster BK; Rofe AM; Xian CJ
    Bone; 2009 Jun; 44(6):1151-62. PubMed ID: 19254786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic analysis of dopamine metabolism in a Parkinsonian model.
    Baranyi M; Milusheva E; Vizi ES; Sperlágh B
    J Chromatogr A; 2006 Jul; 1120(1-2):13-20. PubMed ID: 16580006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.